Vermont H0581 limits reporting of reproductive and gender-affirming care medications to the Vermont Prescription Monitoring System.
Vermont H0581 amends the state's laws to exclude certain medications from reporting to the Vermont Prescription Monitoring System. Specifically, it prevents the reporting of controlled substances prescribed for reproductive health care services or gender-affirming health care services unless the Commissioner of Health determines that reporting is necessary to protect public health. Additionally, if the system contains information about these medications, it must exclude them from sharing with other states' prescription monitoring systems. The bill takes effect on July 1, 2026.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.